Impact of sera from children with active Henoch-Schönlein purpura on human umbilical venous endothelial cells (HUVECs) and protective effects of methylprednisolone against HUVECs injury

Chinese Journal of Contemporary Pediatrics

Volumn 14, Issue 1, 2012, Pages 59-63

  Wu, Lin ^a   Yuan, Li Ping ^a   Fei, Wen Jun ^a   Deng, Fang ^a   Zhang, Qin ^a   Hu, Bo ^a   Lu, Ling ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cytokine; Henoch Sch nlein purpura; Human umbilical venous endothelial cell; Methylprednisolone

Indexed keywords

FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; METHYLPREDNISOLONE; NITRIC OXIDE; NITRIC OXIDE REDUCTASE; TUMOR NECROSIS FACTOR ALPHA;

ANAPHYLACTOID PURPURA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

CELLS, CULTURED; CHEMOKINE CX3CL1; CHILD; CHILD, PRESCHOOL; CYTOKINES; CYTOPROTECTION; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; METHYLPREDNISOLONE; NF-KAPPA B; NITRIC OXIDE; PURPURA, SCHOENLEIN-HENOCH;

EID: 84863079869     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dillon MJ. Henoch-Schönlein purpura: recent advances[J]. Clin Exp Rheumatol, 2007, 25(1 suppl 44): S66-S68.
2. de Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA. Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of initial prognostic factors[J]. J Pediatr, 2007, 83(3): 259-266. (Pubitemid 46883826)
3. Yang YH, Lai HJ, Huang CM, Wang LC, Lin YT, Chiang BL. Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells[J]. Ann Rheum Dis, 2004, 63(11): 1511-1513. (Pubitemid 39433962)
4. Umehara H, Bloom E, Okazaki T, Domae N, Imai T. Fractalkine and vascular injury[J]. Trends Immunol, 2001, 22(11): 602-607.
5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides[J]. Ann Rheum Dis, 2006, 65(7): 936-941.
6. Ben-Mahmud BM, Mann GE, Datti A, Orlacchio A, Kohner EM, Chibber R. Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy[J]. Diabetes, 2004, 53(11): 2968-2976. (Pubitemid 39425923)
7. Van den Berg R, Haenen GR, Van den Berg H, Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress[J]. Br J Nutr, 2001(Suppl 1): S121-S127. (Pubitemid 32916187)
8. Peru H, Soylemezoglu O, Bakkaloglu SA, Elmas S, Bozkaya D, Elmaci AM, et al. Henoch-Schönlein purpura in childhood: clinical analysis of 254 cases over a 3-year period[J]. Clin Rheumatol, 2008, 27(9): 1087-1092.